Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Landon Fine

Orthopaedic Surgery Parker, CO Doctor of Osteopathy

NPI 1134427560 CMS profile 2792617

9949 S Oswego St Ste 200, Parker, CO 80134

Open in the dashboard

General payments

$63,692

328 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Landon Fine of Parker, CO is reported in the CMS Open Payments database as having received $63,692 across 328 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,168 52
2024 General $14,216 40
2023 General $5,304 56
2022 General $14,898 70
2021 General $12,141 43
2020 General $1,730 19
2019 General $9,236 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Landon Fine
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Landon Fine were reported at $6,168. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Landon Fine Orthopaedic Surgery median Middle half National median
2019 $9,236 $644 $140–$2,844 $163
2020 $1,730 $312 $75–$1,860 $114
2021 $12,141 $520 $117–$2,495 $132
2022 $14,898 $598 $128–$2,731 $149
2023 $5,304 $461 $128–$2,264 $160
2024 $14,216 $497 $134–$2,475 $164
2025 $6,168 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SI-BONE, Inc. $26,724 46 payments
  2. Stryker Corporation $10,042 89 payments
  3. Gemini Mountain Medical, LLC $7,321 23 payments
  4. Arthrex, Inc. $6,964 58 payments
  5. Medacta USA, Inc. $3,394 19 payments
  6. Pacira Pharmaceuticals Incorporated $2,902 5 payments
  7. Bone Support Inc. $1,325 4 payments
  8. Encore Medical, LP $1,030 3 payments
  9. Zimmer Biomet Holdings, Inc. $1,026 12 payments
  10. Smith+Nephew, Inc. $410 7 payments
  11. Other $2,554 62 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $25,775 23 payments
  2. Travel and Lodging $14,216 49 payments
  3. Food and Beverage $13,405 247 payments
  4. Education $7,596 8 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,700 1 payment
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $13,874 27 payments
  2. IFUSE IMPLANT SYSTEM $12,206 14 payments
  3. PRO $3,890 12 payments
  4. EXPAREL $2,876 4 payments
  5. GAMMA $1,930 16 payments
  6. PRIMARY SHOULDER $1,751 8 payments
  7. CERAMENTBONE VOID FILLER $1,325 4 payments
  8. Shoulder System $875 2 payments
  9. DJO SURGICAL $790 1 payment
  10. ASNIS $753 3 payments
  11. Other $12,756 186 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

70

Median for Orthopedic Surgery: 203

Drug cost

$186

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 59 $155
Amoxicillin Generic 11 $31

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$121,680

Of which drugs: $33,748

Medicare patients

190

Average age 75

Services billed

6,409

112 women, 78 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Osteoporosis 41%
Chronic kidney disease 28%
Diabetes 26%
Depression 26%
Ischemic heart disease 24%
COPD 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 33 2,260 $221
Injection, methylprednisolone acetate, 80 mg J1040 Office 13 16 $100

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVENITY
  • Amgen Inc. $13
$13 — —
Prolia
  • Amgen Inc. $13
$13 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

328 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record